TECH
Bio-Techne·NASDAQ
--
--(--)
--
--(--)
TECH fundamentals
Bio-Techne (TECH) released its earnings on Feb 4, 2026: revenue was 295.88M (YoY -0.39%), beat estimates; EPS was 0.46 (YoY +9.52%), beat estimates.
Revenue / YoY
295.88M
-0.39%
EPS / YoY
0.46
+9.52%
Report date
Feb 4, 2026
TECH Earnings Call Summary for Q2,2026
- Core Performance: Flat Q2 revenue ($295.9M) with 31.1% operating margin (100bps expansion)
- Growth Verticals: 47% of revenue from high-growth segments (cell therapy, proteomics, spatial, diagnostics)
- Key Drivers: Pharma demand (+low double digits), China/Asia growth (mid-single digits), new product launches
- Challenges: Biotech funding lag (~6-9 months), academic market softness
- Margin Outlook: Sequential gross margin improvement in H2
- M&A Focus: Strategic acquisitions in antibodies, cell therapy, proteomics
EPS
Revenue
Revenue & Expenses
TECH has released its 2026 Q2 earnings report, with revenue of 295.88M, reflecting a YoY change of -0.39%, and net profit of 38.01M, showing a YoY change of 8.94%. The Sankey diagram below clearly presents TECH's revenue sources and cost distribution.
Key Indicators
Bio-Techne (TECH) key financial stats and ratios, covering profitability, financial health, and leverage.
Bio-Techne (TECH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bio-Techne (TECH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bio-Techne (TECH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bio-Techne (TECH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bio-Techne (TECH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Bio-Techne’s earnings call?What is the market's earnings forecast for Bio-Techne next quarter?What is the revenue and EPS growth rate for Bio-Techne year over year?What is Bio-Techne's latest dividend and current dividend yield?What factors drove the changes in Bio-Techne's revenue and profit?What does Bio-Techne do and what are its main business segments?What were the key takeaways from Bio-Techne's earnings call?Did Bio-Techne beat or miss consensus estimates last quarter?
